Cancer Prevention

Spring 2006
Issue 7


Home

From the Editors

Calendar of Events
Aging and Cancer

Nicotine Vaccine: A Promising Treatment for Nicotine Addiction

Molecular Clues to Preventing Tobacco-Related Lung Cancer

Spotlight On...

Smoke-Free Workplace States

Promoting a State of Prevention

Cervical Cancer Vaccine May Be on the Horizon

News from the NCI

Centers of Cancer Nanotechnology Excellence

Issues & Insights

Cancer Prevention Clinical Trials

State Legislation

Federal Legislation

Make Your Voice Heard

Other Information Resources

 

Centers of Cancer Nanotechnology Excellence


Carolina Center of Cancer Nanotechnology Excellence, University of North Carolina, Chapel Hill, North Carolina
Principal investigator: Rudolph Juliano, PhD

Center for Cancer Nanotechnology Excellence Focused on Therapy Response, Stanford University, Palo Alto, California
Principal investigator: Sanjiv Sam Gambhir, MD,PhD

Center of Nanotechnology for Treatment, Understanding, and Monitoring of Cancer, University of California, San Diego, California
Principal investigator: Sadik Esener, PhD

Emory-Georgia Tech Nanotechnology Center for Personalized and Predictive Oncology, Atlanta, Georgia
Principal investigators: Shuming Nie, PhD and Jonathan Simons, MD

MIT-Harvard Center of Cancer Nanotechnology Excellence, Cambridge, Massachusetts
Principal investigators: Robert Langer, PhD and Ralph Weissleder, MD, PhD

Nanomaterials for Cancer Diagnostics and Therapeutics, Northwestern University, Evanston, Illinois
Principal investigator: Chad Mirkin, PhD

Nanosystems Biology Cancer Center, California Institute of Technology, Pasadena, California
Principal investigator: James Heath, PhD

The Siteman Center of Cancer Nanotechnology Excellence at Washington University, St. Louis, Missouri
Principal investigator: Samuel Wickline, MD



 
Back to Top
 
NewYork-Presbyterian. The University Hospitals of Columbia and Cornell